104 related articles for article (PubMed ID: 2223007)
41. Nurse-like cells impact on disease progression in chronic lymphocytic leukemia.
Boissard F; Laurent C; Ramsay AG; Quillet-Mary A; Fournié JJ; Poupot M; Ysebaert L
Blood Cancer J; 2016 Jan; 6(1):e381. PubMed ID: 26771807
[No Abstract] [Full Text] [Related]
42. Alemtuzumab induces enhanced apoptosis in vitro in B-cells from patients with chronic lymphocytic leukemia by antibody-dependent cellular cytotoxicity.
Nückel H; Frey UH; Röth A; Dührsen U; Siffert W
Eur J Pharmacol; 2005 May; 514(2-3):217-24. PubMed ID: 15910809
[TBL] [Abstract][Full Text] [Related]
43. STAT3 and NF-κB cooperatively control in vitro spontaneous apoptosis and poor chemo-responsiveness in patients with chronic lymphocytic leukemia.
Liu FT; Jia L; Wang P; Wang H; Farren TW; Agrawal SG
Oncotarget; 2016 May; 7(22):32031-45. PubMed ID: 27074565
[TBL] [Abstract][Full Text] [Related]
44. 2-Chloro-2'-deoxyadenosine inhibits DNA repair synthesis and potentiates UVC cytotoxicity in chronic lymphocytic leukemia B lymphocytes.
Van Den Neste E; Cardoen S; Husson B; Rosier JF; Delacauw A; Ferrant A; Van den Berghe G; Bontemps F
Leukemia; 2002 Jan; 16(1):36-43. PubMed ID: 11840261
[TBL] [Abstract][Full Text] [Related]
45. Aberrant morphology, proliferation, and apoptosis of B-cell chronic lymphocytic leukemia cells.
Bueso-Ramos CE; Ferrajoli A; Medeiros LJ; Keating MJ; Estrov Z
Hematology; 2004 Aug; 9(4):279-86. PubMed ID: 15621735
[TBL] [Abstract][Full Text] [Related]
46. Activity of vinorelbine on B-chronic lymphocytic leukemia cells in vitro.
Bernabei PA; Landini I; Bartolozzi B; Banchelli I; Degli Innocenti o Nocentini A; Santini V; Ematologia UO
Adv Exp Med Biol; 1999; 457():473-6. PubMed ID: 10500824
[TBL] [Abstract][Full Text] [Related]
47. The antiapoptotic effects of blood constituents in patients with chronic lymphocytic leukemia.
Bomstein Y; Yuklea M; Radnay J; Shapiro H; Afanasyev F; Yarkoni S; Lishner M
Eur J Haematol; 2003 May; 70(5):290-5. PubMed ID: 12694164
[TBL] [Abstract][Full Text] [Related]
48. Role of myeloid cell factor-1 (Mcl-1) in chronic lymphocytic leukemia.
Johnston JB; Paul JT; Neufeld NJ; Haney N; Kropp DM; Hu X; Cheang M; Gibson SB
Leuk Lymphoma; 2004 Oct; 45(10):2017-27. PubMed ID: 15370246
[TBL] [Abstract][Full Text] [Related]
49. Highly similar genomic landscapes in monoclonal B-cell lymphocytosis and ultra-stable chronic lymphocytic leukemia with low frequency of driver mutations.
Agathangelidis A; Ljungström V; Scarfò L; Fazi C; Gounari M; Pandzic T; Sutton LA; Stamatopoulos K; Tonon G; Rosenquist R; Ghia P
Haematologica; 2018 May; 103(5):865-873. PubMed ID: 29449433
[TBL] [Abstract][Full Text] [Related]
50. Monoclonal B lymphocytosis versus chronic lymphocytic leukemia: factors affecting implementation of an absolute threshold.
Rollins-Raval MA; Fisher J; Craig FE
Cytometry B Clin Cytom; 2013 May; 84(3):149-56. PubMed ID: 23475845
[TBL] [Abstract][Full Text] [Related]
51. Apoptosis and secondary necrosis of lymphocytes in culture.
Vermes I; Haanen C; Richel DJ; Schaafsma MR; Kalsbeek-Batenburg E; Reutelingsperger CP
Acta Haematol; 1997; 98(1):8-13. PubMed ID: 9210907
[TBL] [Abstract][Full Text] [Related]
52. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
[TBL] [Abstract][Full Text] [Related]
53. Prognostic features and survival in young adults with early/intermediate chronic lymphocytic leukemia (B-CLL): a single institution study.
Dhodapkar M; Tefferi A; Su J; Phyliky RL
Leukemia; 1993 Aug; 7(8):1232-5. PubMed ID: 8350623
[TBL] [Abstract][Full Text] [Related]
54. Prognostic significance of lymphocyte morphology in patients with advanced chronic lymphocytic leukemia treated with first line therapy of fludarabine + prednisone.
Mauro FR; Gentile M; Mancini F; Giannarelli D; Guarini A; De Propriis MS; Cerretti R; Foa R
Haematologica; 2002 Jun; 87(6):602-8. PubMed ID: 12031916
[TBL] [Abstract][Full Text] [Related]
55. Modulation of NF-kappa B activity and apoptosis in chronic lymphocytic leukemia B cells.
Furman RR; Asgary Z; Mascarenhas JO; Liou HC; Schattner EJ
J Immunol; 2000 Feb; 164(4):2200-6. PubMed ID: 10657675
[TBL] [Abstract][Full Text] [Related]
56. EFFECTS OF PHYTOHAEMAGGLUTININ ON BLOOD-CULTURES OF CHRONIC LYMPHOCYTIC LEUKAEMIAS.
BERNARD C; GERALDES A; BOIRON M
Lancet; 1964 Mar; 1(7334):667-8. PubMed ID: 14107951
[No Abstract] [Full Text] [Related]
57. A clinical update on chronic lymphocytic leukemia. I. Diagnosis and prognosis.
Tefferi A; Phyliky RL
Mayo Clin Proc; 1992 Apr; 67(4):349-53. PubMed ID: 1548950
[TBL] [Abstract][Full Text] [Related]
58. No effect of lysis solutions on absolute CD19+ lymphocytes count and CD45 index in chronic lymphocytic leukemia.
Mekouar H; Mullier F; Dinon Q; Bailly N; Cornet Y; Chatelain B
Cytometry B Clin Cytom; 2011 Nov; 80(6):369-72. PubMed ID: 21638772
[TBL] [Abstract][Full Text] [Related]
59. Aberrant expression of c-met and HGF/c-met pathway provides survival advantage in B-chronic lymphocytic leukemia.
Eksioglu-Demiralp E; Akdeniz T; Bayik M
Cytometry B Clin Cytom; 2011 Jan; 80(1):1-7. PubMed ID: 20809501
[TBL] [Abstract][Full Text] [Related]
60. Intracellular tumor necrosis factor production by T- and B-cells in B-cell chronic lymphocytic leukemia.
Bojarska-Junak A; Rolinski J; Wasik-Szczepaneko E; Kaluzny Z; Dmoszynska A
Haematologica; 2002 May; 87(5):490-9. PubMed ID: 12010662
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
